ACE and hydrops fetalis: In PARADIGM-HF (Prospective Comparison of ARN Inhibitors With ACE Inhibitors to Determine Impact on Global Mortality and Morbidity in HF Trial), the mean dose of sacubitril/valsartan at the last study assessment was 375 ± 71 mg daily (the target dose was 400 mg per day) [37].